
Lanting Capital
Asia, Zhejiang, China, Hangzhou'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Description
Lanting Capital is a venture capital firm that focuses on healthcare industry and especially pharmaceuticals.
Investor Profile
Lanting Capital has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 33% of its total and boasts 2 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series C, Series B rounds (top funding stages).
- Majority of deals are located in China, United Kingdom.
- Strong thematic focus on Artificial Intelligence (AI), Hardware, Machine Learning.
Stage Focus
- Series A (33%)
- Series C (33%)
- Series B (33%)
Country Focus
- China (67%)
- United Kingdom (33%)
Industry Focus
- Artificial Intelligence (Ai)
- Hardware
- Machine Learning
- Robotics
- Clinical Trials
- Internet Of Things
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.